FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
60 letters match. Newest first.
-
DrugsPine Pharmaceuticals, LLC
FDA cited outsourcing facility Pine Pharmaceuticals in Tonawanda, NY, for insanitary sterile compounding conditions and CGMP failures after a November 2025 inspection.
High risk -
DrugsFagron BV
FDA warns Fagron's Canton, MA sterile compounding site over airflow, cleaning and investigation failures, prompting a recall.
High risk -
DrugsProRx LLC
ProRx LLC, an outsourcing facility, made sterile compounded drugs under insanitary conditions and without required 503B eligibility.
High risk -
DrugsRC Outsourcing, LLC
FDA warned outsourcing facility RC Outsourcing of Lowellville, Ohio, that its sterile drugs were made under insanitary conditions that risk contamination.
High risk -
DrugsThrive Health and Wellness, LLC dba Thrive Health Solutions
FDA warned Thrive Health and Wellness, a Colorado repackager, that sterile drugs were made in unsanitary conditions and sold without approval.
High risk -
DrugsApollo Care, LLC
FDA cited Apollo Care for insanitary conditions and quality failures in sterile compounded drugs, including a sterility-assurance recall.
High risk -
DrugsApothecary Pharma, LLC
FDA warns Apothecary Pharma, an outsourcing facility, that its sterile compounded drugs were made under insanitary conditions.
High risk -
DrugsGenoGenix LLC
FDA warns GenoGenix over insanitary sterile compounding, endotoxin-contaminated NAD+, and unapproved drugs.
High risk -
DrugsMedisourceRx
MedisourceRx failed to report a serious adverse event and had inadequate procedures, so its compounded drugs lost legal exemptions.
Medium -
DrugsBoothwyn Pharmacy, LLC
Boothwyn Pharmacy made sterile drugs in insanitary conditions and shipped lots that failed sterility and potency tests.
High risk -
DrugsRevive Rx LLC dba Revive Rx Pharmacy
FDA warns Revive Rx Pharmacy over insanitary production of sterile compounded drugs, citing contamination risks.
High risk -
DrugsPQ Pharmacy, LLC
FDA warns PQ Pharmacy, a Florida sterile drug compounder, that its products were made under unsafe conditions.
High risk -
DrugsTurbare Manufacturing
FDA warns outsourcing facility Turbare Manufacturing of Conway, Arkansas, for making sterile drugs under insanitary conditions.
High risk -
DrugsWells Pharma of Houston, LLC
FDA warns Wells Pharma of Houston over sterile compounded drugs made under insanitary conditions.
High risk -
DrugsMatthew Stern, CEO MyStart Health LLC.
FDA warns MyStart Health over 'Generic Ozempic' claims for compounded semaglutide.
Low -
DrugsStaska Pharmaceuticals, Inc.
FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.
High risk -
DrugsOSRX, Inc.
OSRX, a Montana compounding facility, made sterile ophthalmic drugs under insanitary conditions with quality and labeling failures.
High risk -
DrugsTailstorm Health Inc. dba Medivant Health
Tailstorm Health (Medivant Health) sterile compounded drugs had insanitary conditions and current good manufacturing practice failures, prompting a bevacizumab recall.
High risk -
DrugsEmpower Clinic Services, LLC dba Empower Pharmacy
FDA warns Empower Pharmacy that insanitary conditions in sterile drug compounding put patients at risk.
High risk -
DrugsEmpower Clinic Services, LLC dba Empower Pharma
FDA warns Empower Pharma over sterile drug manufacturing deficiencies, labeling, and unapproved compounded drugs after August 2024 inspection.
High risk -
DrugsNubratori, Inc. dba Nubratori Rx
FDA cited Nubratori Rx, a sterile compounding outsourcing facility, for insanitary conditions and manufacturing quality failures that may contaminate its drug products.
High risk -
DrugsAnnovex Pharma, Inc.
FDA warns outsourcing facility Annovex Pharma in Lorton, VA, over contaminated sterile drug production and missed FDA reports.
High risk -
DrugsRight Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals
FDA warned outsourcing facility Carie Boyd Pharmaceuticals in Irving, TX that sterile drug production had airflow, media fill and contamination control failures.
High risk -
DrugsProRx, LLC
FDA warns ProRx, LLC about insanitary sterile compounded-drug production and manufacturing-quality failures.
High risk -
DrugsFagron Compounding Services, LLC dba Fagron Sterile Service
FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.
High risk -
DrugsStokes Healthcare Inc. dba Epicur Pharma
Sterile compounding facility Epicur Pharma made drugs under insanitary conditions and with serious quality failures, FDA says.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.
High risk -
DrugsNorthern VA Compounders PLLC, dba Akina Pharmacy
FDA warns Akina Pharmacy over unsafe production of compounded drugs and sterility risks.
High risk -
DrugsQuVa Pharma, Inc.
FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.
High risk -
DrugsCurexa – East, LLC dba Curexa
Curexa - East made compounded drugs under insanitary conditions, with contamination and inadequate cleaning, FDA says.
High risk -
DrugsSouthern Tier Home Infusion, Inc. dba Pharmacy Innovations
FDA warned compounding pharmacy Pharmacy Innovations that its sterile drugs were made under insanitary conditions and without valid patient prescriptions.
High risk -
DrugsUS Specialty Formulations, LLC
US Specialty Formulations, a drug compounder registered as an outsourcing facility, made sterile compounded drugs under insanitary conditions.
High risk -
DrugsPharmacy Plus, Inc., dba Vital Care Compounder
FDA warned Pharmacy Plus (Vital Care Compounder) that its sterile compounded drugs were made under insanitary conditions, risking contamination.
High risk -
DrugsCarolina Infusion
FDA warns Carolina Infusion over compounded drugs made without valid prescriptions and under insanitary conditions, including sterile products.
High risk -
DrugsImprimisRx NJ
FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.
High risk -
DrugsNew England Life Care, Inc. dba Advanced Compounding Solutions
FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.
High risk -
DrugsBelmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy
FDA warns Drug Depot dba APS Pharmacy over compounded drugs made with ineligible bulk substances.
Medium -
DrugsNorth American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
FarmaKeio, a Texas compounding pharmacy, made sterile drugs under insanitary conditions that put patients at risk.
High risk -
DrugsOptum Infusion Services 308 LLC
FDA warned Optum Infusion Services 308 LLC about insanitary conditions in sterile drug compounding after inspection found vermin and microbial contamination.
High risk -
DrugsNephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, LLC
FDA warned Nephron Sterile Compounding Center about insanitary sterile drug production and sterility assurance failures found in a 2022 inspection.
High risk -
DrugsVita Pharmacy, LLC dba Talon Pharmacy of Boerne
FDA warned Talon Pharmacy of Boerne that it made sterile compounded drugs under insanitary conditions that could contaminate them.
High risk -
DrugsHybrid Pharma, LLC
FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.
High risk -
DrugsNew Vitalis, LLC dba New Vitalis Pharmacy
New Vitalis Pharmacy made sterile compounded drugs under insanitary conditions that risked contamination.
High risk -
DrugsAge Management Institute Santa Barbara
FDA cited Age Management Institute Santa Barbara for insanitary sterile compounding of IV drugs, including dirty equipment and expired ingredients.
High risk -
DrugsMed Shop Total Care, Inc.
FDA warns Med Shop Total Care about insanitary conditions in sterile drug compounding.
High risk -
DrugsInnoveix Pharmaceuticals Inc
FDA cited Innoveix Pharmaceuticals for insanitary conditions in producing sterile compounded drugs, including improper sterilization and aseptic practices.
High risk -
DrugsApothecary Health Solutions/Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop
FDA cited Carie Boyd's Prescription Shop for compounded drugs that failed outsourcing-facility labeling and reporting rules.
Medium -
DrugsAdvanced Nutriceuticals, LLC dba The Guyer Institute of Molecular Medicine
Advanced Nutriceuticals compounded sterile drugs without required prescriptions and under insanitary conditions, FDA says.
High risk -
DrugsMatthew 7:25 Inc dba Thrive Pharmacy
FDA says Thrive Pharmacy compounded drugs without valid prescriptions and released subpotent buprenorphine troches, making them adulterated and misbranded.
High risk -
DrugsInfusion Options, Inc.
FDA found Infusion Options produced sterile compounded drugs under insanitary conditions and failed 503B labeling and reporting rules.
High risk